Evidence map›Paper›PMID 22058055›Full record

ArticleCurrent protocols in toxicology2011

Preparation of epithelial and mesenchymal stem cells from murine mammary gland.

Ian Guest, Zoran Ilic, Jun Ma

Open access · greenAbstract read
In one paragraph

Article in Current protocols in toxicology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ian GuestDepartment of Translational Medicine, Wadsworth Laboratories, New York State Department of Health, Albany, USA.
Zoran Ilic
Jun Ma
New York State Department of Health · USWadsworth Center · US

Funding

STEM CELLS AND HEPATOCARCINOGENESISR01CA112481 · NCI · ORDWAY RESEARCH INSTITUTE, INC. · PI SELL, STEWART · 2005 to 2009
$1.3M
STEM CELLS AND AGINGR01AG023510 · NIA · WADSWORTH CENTER · PI SELL, STEWART · 2005 to 2008
$899k
NCI NIH HHS 1R01CA112481-01A1NCI NIH HHS R01 CA112481NIA NIH HHS R01 AG023510PHS HHS 1R01AGO23510-01A1
6 · The paper itself

Abstract

The mammary gland is a complex organ consisting of multiple cell types that undergo extensive remodeling during pregnancy and involution, cyclical changes that suggest the existence of a resident stem cell population that is responsible for remarkable tissue regeneration. The basic functional unit of the mammary gland is the terminal duct lobular unit, which invades the stromal tissue (fat, connective tissue, blood vessels, etc.). Luminal epithelial cells line the ducts while outer myoepithelial cells secrete the basal lamina that separates the mammary gland parenchyma from the mesenchymal cells of the stroma. Within the epithelial cell population of the ducts resides the mammary gland stem cells and it is believed that this population is the origin of the mammary gland cancer stem cells as well. In the mouse, epithelial stem cells can be separated from mesenchymal cells on the basis of CD24, CD44, and CD49f expression. This allows for the determination of both normal and cancer stem cell potential of these two populations and permits investigation into their interaction in tumor development.

Indexed as

AnimalsCell Culture TechniquesEpithelial CellsFemaleFlow CytometryMammary Glands, AnimalMammary Neoplasms, ExperimentalMesenchymal Stem CellsMiceMice, TransgenicNeoplastic Stem Cells

Identifiers

PMID22058055
PMCPMC3402019
OpenAlexW1481792633

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.